Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Intellect Disabil Res ; 65(11): 971-988, 2021 11.
Article in English | MEDLINE | ID: mdl-34542212

ABSTRACT

BACKGROUND: Moving around and being physically active can often be challenging for people with a visual impairment. The combination of a visual and intellectual disability can make being physically active even more difficult. The aim of the current study was to examine whether a technological device for physical activity promotion would be associated with more movement and whether using it would be experienced as enjoyable for people with visual and intellectual disabilities. METHODS: A randomised multiple baseline design was used for this study. The participants were nine adults with a visual impairment and an IQ between 20 and 50. As participants interacted with the Light Curtain, movement was measured with triaxial accelerometers embedded in the Empatica E4 wristband. Independent observers scored activity, alertness and well-being from video-recordings using the following observation lists: the Happiness Feature Score (HFS) and the Arousal and Valence Scale (AVS). RESULTS: Physical activity measured with the accelerometer and positive excitement measured with the AVS significantly increased among participants when they were engaged with the Light Curtain compared with care-as-usual activities. Well-being measured with the HFS did not show a significant difference between the baseline and intervention phases. CONCLUSIONS: Engagement with the Light Curtain increased physical activity and positive excitement in persons with visual and intellectual disabilities, but more research is necessary to understand how the Light Curtain might affect happiness and well-being.


Subject(s)
Intellectual Disability , Adult , Exercise , Humans , Pilot Projects
2.
Heart Fail Rev ; 18(4): 409-27, 2013 Jul.
Article in English | MEDLINE | ID: mdl-22723048

ABSTRACT

A systematic literature review was conducted to summarize the existing evidence on presumed determinants of heart failure (HF) medication adherence. The aim was to assess the evidence and provide directions for future medication adherence interventions for HF patients. Based on a search in relevant databases and a quality assessment, eleven articles were included in the review. A best evidence synthesis was used to combine the results of presumed determinants that were found more than once in the literature. Results were classified according the World Health Organization's (WHO) multidimensional adherence model. Results demonstrated a relationship between having been institutionalized in the past (including hospitalizations and nursing home visits) and higher adherence levels. This finding is related to the healthcare system dimension of the WHO model. The presumed determinants related to the other dimensions, such as social and economic factors, condition-related, therapy-related, and patient-related factors of the multidimensional adherence model all had inconsistent evidence. However, there was also an indication that patients' educational level and the number of healthcare professionals they have visited are not related to higher adherence levels. Based on the current review, HF patients who have been institutionalized in the past are more adherent to HF medication. Many other presumed determinants were investigated, but displayed inconsistent evidence. Due to the lack of evidence, it was not possible to make recommendations for future interventions.


Subject(s)
Cardiovascular Agents/administration & dosage , Heart Failure/drug therapy , Medication Adherence , Evidence-Based Medicine , Health Knowledge, Attitudes, Practice , Humans , Patient Education as Topic , Risk Assessment , Risk Factors , World Health Organization
3.
Eur Rev Med Pharmacol Sci ; 16 Suppl 3: 1-9, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22957412

ABSTRACT

OBJECTIVES: Oxidative stress is increasingly recognised as a pivotal factor that plays a number of roles in the inflammatory response to environmental signals. It has been claimed that Aesculus hippocastanum extracts have antioxidant and anti-inflammatory activity, but these claims are mainly based on the results of chemical reactions and folk-medicine. MATERIALS AND METHODS: The aim of this study was to examine whether a bark extract of Aesculus hippocastanum interferes with reactive oxygen/nitrogen species (ROS/RNS) during the course of human neutrophil respiratory bursts, and to establish the lowest concentration at which it still has antioxidant activity by means of luminol amplified chemiluminescence (LACL). We also studied its ability to counteract lipid peroxidation (LPO) in human cells. Before investigating its antioxidant effects on human cells, we analysed its scavenging activity against ABTS*+, hydroxyl radical, superoxide anion, and Fremy's salt (those last three by means of electron paramagnetic resonance (EPR) spectrometry). RESULTS: The extract of Aesculus hippocastanum exerted its anti-ROS/RNS activity in a concentration-dependent manner with significant effects being observed for even very low concentrations: 10 microg/ml without L-Arg, and 5 microg/ml when L-Arg was added to the fMLP test. The LPO assay confirmed these results, which were paralleled by the EPR study. CONCLUSIONS: These findings are interesting for improving the antioxidant network and restoring redox balance in human cells, and extend the possibility of using plant-derived molecules to antagonise the oxidative stress generated in living organisms when the balance is in favour of free radicals as a result of the depletion of cell antioxidants.


Subject(s)
Aesculus/chemistry , Antioxidants/pharmacology , Free Radical Scavengers/pharmacology , Plant Extracts/pharmacology , Antioxidants/administration & dosage , Antioxidants/isolation & purification , Dose-Response Relationship, Drug , Electron Spin Resonance Spectroscopy , Free Radical Scavengers/administration & dosage , Free Radical Scavengers/isolation & purification , Humans , Lipid Peroxidation/drug effects , Luminescence , Neutrophils/drug effects , Neutrophils/metabolism , Plant Bark , Plant Extracts/administration & dosage , Reactive Oxygen Species/metabolism
4.
Heart Fail Rev ; 17(3): 367-85, 2012 May.
Article in English | MEDLINE | ID: mdl-22134397

ABSTRACT

Self-care is an important aspect of heart failure (HF) management. Information on the determinants of self-care is necessary for the development of self-care promotion interventions. HF self-care includes self-care management, self-care maintenance, sodium, fluid and alcohol intake restriction, physical activity, smoking cessation, monitoring signs and symptoms and keeping follow-up appointments. To assess the evidence regarding presumed determinants of HF self-care and make recommendations for interventions to promote self-care behavior among HF patients, a systematic literature review was conducted. Based on inclusion and exclusion criteria and a quality assessment, twenty-six articles were included. A best evidence synthesis was used. Results showed that the length of time since patients' diagnosis with HF is positively related to their performance of self-care maintenance. Moreover, it was found that HF patients' perceived benefits and barriers are related to their restriction of sodium intake, and that patients with type-D personality are less likely to consult medical professionals. There was also evidence for a few non-significant relationships. All other evidence was inconsistent, mainly due to insufficient evidence. Interventions that aim to increase the performance of self-care maintenance can teach newly diagnosed patients the skills that are usually attained with experience acquired as a result of living with HF for a longer time. Perceived benefits and barriers of restricting sodium intake could be targeted in interventions for sodium intake reduction among HF patients. Finally, interventions for the promotion of adequate consulting of medical professionals can specifically target HF patients with a type-D personality.


Subject(s)
Heart Failure/therapy , Self Care , Evidence-Based Medicine , Female , Health Behavior , Humans , Male
5.
Eur J Pharmacol ; 427(1): 1-5, 2001 Sep 07.
Article in English | MEDLINE | ID: mdl-11553357

ABSTRACT

N-[2-[4-(4-Chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide (PB12), a potent and selective dopamine D(4) receptor ligand, was used as a probe for the direct determination of the dopamine D(4) receptor density in rat striatum as an alternative to the subtraction method. The experiment was performed using [(3)H]spiroperidol to label D(2), D(3) and D(4) receptors and PB12 to determine directly dopamine D(4) receptor specific binding. The determined B(max) value was 82 fmol/mg protein. The contribution of the dopamine D(4) receptor to the overall population of D(2)-like receptors was 63%; however, this value cannot be considered reliable because of the observed difference in the kinetic profiles of D(2), D(3) and D(4) receptors.


Subject(s)
Benzamides/metabolism , Corpus Striatum/metabolism , Piperazines/metabolism , Receptors, Dopamine D2/metabolism , Animals , Benzamides/pharmacology , Binding, Competitive/drug effects , Corpus Striatum/drug effects , Dose-Response Relationship, Drug , Haloperidol/pharmacology , Kinetics , Male , Membranes/drug effects , Membranes/metabolism , Piperazines/pharmacology , Radioligand Assay , Rats , Rats, Wistar , Receptors, Dopamine D4 , Spiperone/metabolism , Time Factors , Tritium
6.
Cardiovasc Intervent Radiol ; 15(4): 247-50, 1992.
Article in English | MEDLINE | ID: mdl-1394363

ABSTRACT

Methyl tert-butyl-ether (MTBE) was successfully used for stone dissolution in 2 patients with multiple bile duct cholesterol stones. The presence of a biliary-enteric anastomosis precluded the endoscopic approach. Because of leakage of MTBE into the bowel, dissolution time ranged from 7.5 to 36 h. No significant complications other than mild nausea were encountered. No recurrence of stone formation has been found at a follow-up varying from 9 to 12 months.


Subject(s)
Bile Ducts, Intrahepatic , Cholelithiasis/therapy , Ethers/therapeutic use , Methyl Ethers , Solvents/therapeutic use , Adult , Bile Duct Diseases/diagnostic imaging , Bile Duct Diseases/metabolism , Bile Duct Diseases/therapy , Choledochostomy , Cholelithiasis/chemistry , Cholelithiasis/diagnostic imaging , Cholesterol/analysis , Humans , Male , Middle Aged , Radiography
SELECTION OF CITATIONS
SEARCH DETAIL
...